Sangamo Therapeutics Announces Second Quarter 2021 Conference Call and Webcast

Rhea-AI Summary

Sangamo Therapeutics (Nasdaq: SGMO) announced the release of its second quarter 2021 financial results, scheduled for August 5, 2021, after market close. This will be followed by a conference call at 4:30 p.m. ET, open to the public via phone and webcast. During the call, the company will discuss its financial performance and provide updates on its business operations. Dial-in numbers are provided for domestic and international callers, and a replay will be available for one week post-call.

Positive

• Scheduled financial results release indicates transparency and communication with investors.
• Conference call allows for direct interaction with management and insights into business progress.

Negative

• None.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its second quarter 2021 financial results after the market closes on Thursday, August 5, 2021. The press release will be followed by a conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide business updates.

The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 1971045. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. A conference call replay will be available for one week following the conference call. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 1971045.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005265/en/

FAQ

When will Sangamo Therapeutics release its second quarter 2021 financial results?

Sangamo Therapeutics will release its second quarter 2021 financial results after market close on August 5, 2021.

What time is the Sangamo Therapeutics conference call scheduled?

The conference call is scheduled for 4:30 p.m. ET on August 5, 2021.

How can I listen to the Sangamo Therapeutics conference call?

You can listen to the conference call via telephone or webcast, with dial-in numbers provided for domestic and international callers.

Will there be a replay of the Sangamo Therapeutics conference call?

Yes, a replay of the conference call will be available for one week following the event.

What is Sangamo Therapeutics known for?

Sangamo Therapeutics is known for its genomic medicine pipeline and proprietary zinc finger genome engineering technology.